Duchenne Muscular Dystrophy
Oxford University Press, 2015 - Medical - 320 pages
Duchenne Muscular Dystrophy, an inherited and progressive muscle wasting disease, is one of the most common single gene disorders found in the developed world. In this fourth edition of the classic monograph on the topic, Alan Emery and Francesco Muntoni are joined by Rosaline Quinlivan, Consultant in Neuromuscular Disorders, to provide a thorough update on all aspects of the disorder.
Recent understanding of the nature of the genetic defect responsible for Duchenne Muscular Dystrophy and isolation of the protein dystrophin has led to the development of new theories for the disease's pathogenesis. This new edition incorporates these advances from the field of molecular biology, and describes the resultant opportunities for screening, prenatal diagnosis, genetic counselling and from recent pioneering work with anti-sense oligonucleotides, the possibility of effective RNA therapy. Although there is still no cure for the disorder, there have been significant developments concerning the gene basis, publication of standards of care guidelines, and improvements in management leading to significantly longer survival, particularly with cardio-pulmonary care. The authors also investigate other forms of pharmacological, cellular and gene therapies.
Duchenne Muscular Dystrophy will be essential reading not only for scientists and clinicians, but will also appeal to therapists and other professionals involved in the care of patients with muscular dystrophy.
What people are saying - Write a review
We haven't found any reviews in the usual places.
1 Introduction to Duchenne muscular dystrophy
2 History of the disease
3 Clinical features
4 Confirmation of the diagnosis
5 Differential diagnosis
6 Involvement of tissues other than skeletal muscle
7 Biochemistry of Duchenne muscular dystrophy
12 Genetic counselling
Appendix 1 Egen Klassifikation Scale Version 2 EK2
Appendix 2 The North Star Ambulatory Assessment
Appendix 3 Muscular Dystrophy Associations and Groups in Various Countries 2013
9 Molecular pathology
Other editions - View all
abnormal activity affected boys ambulation appear approach assessment associated become calcium cardiac carrier cells changes Chapter child chromosome clinical compared Completed condition considered controls corticosteroids counselling creatine deficiency deletion detail detection diagnosis disease disorder Duchenne muscular dystrophy dystrophin early Email Emery enzymes et al evidence example exon expression female function further gene genetic glucose head human important increased indicated individuals involvement later locus male mean membrane mother muscle fibres mutations needs Neuromuscular normal observed occur parents patients position possible present probability problems progressive proportion protein randomized recent reduced referred regeneration region relatives reported respiratory risk SCK levels severe shown significant skeletal muscle stages Stands studies suggest Table technique tion tissue treatment trials usually various walk weakness Website Western blot whilst X-linked